Ewing J C, White J M, Rattray A, Lessells A, Mackie M J
Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road MBX 20 4, Manchester, UK.
Hematology. 2003 Aug;8(4):211-20. doi: 10.1080/1024533031000135685.
All cases S16 years of age with a histological diagnosis of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) presented in Scotland between 1 January 1994 and 31 December 1996 were registered prospectively in the Scotland and Newcastle Lymphoma Group database by a process of total registration. The census population of Scotland in 1996-1997 was 5.1 million. One thousand seven hundred and sixty three patients were registered with NHL and 350 patients with HD. These patients have been followed up for a median of 47 months in the case of NHL and 51 months for HD cases. Actuarial 5-year survival for adult NHL was 35% and for HD, 75%. Outcome for both NHL and HD was particularly poor in the population over 60 years with median survival of 18 months for NHL and 27 months for HD. When analysis of survival was related to degree of material deprivation using the Carstairs score a significantly poorer survival was seen for NHL with increasing deprivation that could not be explained by a different pattern of age or stage at presentation. Deprivation had no impact on incidence or survival in HD. Analysis of impact of caseload of the physician initiating therapy showed no significant difference in 5-year survival.
1994年1月1日至1996年12月31日期间在苏格兰出现的所有年龄在16岁及以上、经组织学诊断为非霍奇金淋巴瘤(NHL)和霍奇金病(HD)的病例,通过全面登记程序前瞻性地登记在苏格兰和纽卡斯尔淋巴瘤组数据库中。1996 - 1997年苏格兰的普查人口为510万。登记了1763例NHL患者和350例HD患者。这些患者中,NHL患者的中位随访时间为47个月,HD患者为51个月。成人NHL的精算5年生存率为35%,HD为75%。60岁以上人群中NHL和HD的预后特别差,NHL的中位生存期为18个月,HD为27个月。当使用卡斯尔斯评分将生存分析与物质剥夺程度相关联时,发现NHL随着剥夺程度的增加生存率显著降低,且这种情况无法用就诊时不同的年龄或分期模式来解释。剥夺对HD的发病率或生存率没有影响。对启动治疗的医生的病例量影响的分析显示,5年生存率没有显著差异。